ARCHIVES

FDA Approves Imaging Agent For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

AOR And PRN, Two Largest Oncology Practice Management Firms, To Merge

December 18, 1998

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

Bill Pressures HCFA To Launch Project On Reimbursement for Cancer Trials

July 26, 1996

Samuel Broder Plans To Leave Celera.

September 10, 2010

Cancer Researchers Ask Congress for Full Bypass Budge Funding

April 27, 1990